# A Study of GEN1106 in Participants With Solid Tumors

> **NCT07416123** · PHASE1 · RECRUITING · sponsor: **Genmab** · enrollment: 103 (estimated)

## Conditions studied

- Solid Tumors
- Urothelial Carcinoma

## Interventions

- **BIOLOGICAL:** GEN1106

## Key facts

- **NCT ID:** NCT07416123
- **Lead sponsor:** Genmab
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-14
- **Primary completion:** 2029-04-05
- **Final completion:** 2029-06-25
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07416123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07416123, "A Study of GEN1106 in Participants With Solid Tumors". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07416123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*